Anti-B Raf (phospho S446) antibody (ab76200)

Overview

• Product nameAnti-B Raf (phospho S446) antibodySee all B Raf primary antibodies ...
• Description
  Rabbit polyclonal to B Raf (phospho S446)
• Specificityab76200 may cross-react with CRaf and ARaf as the sequence used as immunogen has high homology to CRaf (Ser-338) and ARaf (Ser-299).
• Tested applicationsWB, ELISA more details
• Species reactivity
  Reacts with: Human
  Predicted to work with: a wide range of other species
• Immunogen

  Synthetic phosphopeptide corresponding to amino acids surrounding serine 446 in human B Raf conjugated to KLH

• Positive controlHuman Jurkat cells treated with calyculin A (100 nM) for 30 min.

Properties

• FormLiquid
• Storage instructionsStore at -20°C. Stable for 12 months at -20°C
• Storage bufferPreservative: 0.05% Sodium Azide
  Constituents: 50% Glycerol, PBS, 1mg/ml BSA
• Concentration information loading...
• PurityImmunogen affinity purified
• Purification notesab76200 was cross-adsorbed to phospho-B Raf (Ser-579) peptide before affinity purification using phospho-B Raf (Ser-446) peptide.
• Clonality Polyclonal
• IsotypeIgG
• Research Areas
  • Cancer
  • Oncoproteins/suppressors
  • Oncoproteins
  • Signal transducers

  • Signal Transduction
  • Protein Phosphorylation
  • Ser / Thr Kinases
  • Other Kinases

  • Signal Transduction
  • Protein Phosphorylation
  • Tyrosine Kinases
  • Other

  • Cell Biology
  • Cell Cycle
  • Cell differentiation

  • Cell Biology
  • Apoptosis
  • Intracellular
  • Kinases

Applications

Target

• FunctionInvolved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron.
• Tissue specificityBrain and testis.
• Involvement in diseaseNote=Defects in BRAF are found in a wide range of cancers.
  Defects in BRAF may be a cause of colorectal cancer (CRC) [MIM:114500].
  Defects in BRAF are involved in lung cancer (LNCR) [MIM:211980].
  Defects in BRAF are involved in non-Hodgkin lymphoma (NHL) [MIM:605027]. NHL is a cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss.
  Defects in BRAF are a cause of cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150]; also known as cardio-facio-cutaneous syndrome. CFC syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. The inheritance of CFC syndrome is autosomal dominant.
  Defects in BRAF are the cause of Noonan syndrome type 7 (NS7) [MIM:613706]. Noonan syndrome is a disorder characterized by facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears. Other features can include short stature, a short neck with webbing or redundancy of skin, cardiac anomalies, deafness, motor delay and variable intellectual deficits.
  Defects in BRAF are the cause of LEOPARD syndrome type 3 (LEOPARD3) [MIM:613707]. LEOPARD3 is a disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness.
  Note=A chromosomal aberration involving BRAF is found in pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation.
• Sequence similaritiesBelongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
  Contains 1 phorbol-ester/DAG-type zinc finger.
  Contains 1 protein kinase domain.
  Contains 1 RBD (Ras-binding) domain.
• Cellular localizationNucleus. Cytoplasm. Cell membrane. Colocalizes with RGS14 and RAF1 in both the cytoplasm and membranes.

Target information above from: UniProt accession P15056 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) .

Information by UniProt
• Database links
  • Entrez Gene: 673 Human
  • Omim: 164757 Human
  • SwissProt: P15056 Human
  • Unigene: 550061 Human

• Alternative names
  FLJ95109 antibody94 kDa B raf protein antibodyB raf 1 antibody

  B Raf proto oncogene serine threonine protein kinase antibodyBRAF 1 antibodyBRaf antibodyBRAF_HUMAN antibodyBRAF1 antibodycRmil antibodyMGC126806 antibodyMGC138284 antibodyMurine sarcoma viral (v-raf) oncogene homolog B1 antibodyMurine sarcoma viral v raf oncogene homolog B1 antibodyNS7 antibodyp94 antibodyProto-oncogene B-Raf antibodyProto-oncogene c-Rmil antibodyRAFB 1 antibodyRAFB1 antibodySerine/threonine-protein kinase B-raf antibodyv raf murine sarcoma viral oncogene homolog B1 antibodyv-Raf murine sarcoma viral oncogene homolog B1 antibody

  see all

Anti-B Raf (phospho S446) antibody images

• 

  Western blot - B Raf (phospho S446) antibody (ab76200)
  All lanes : Anti-B Raf (phospho S446) antibody (ab76200) at 1/1000 dilution
  
  Lane 1 : Human Jurkat cells treated with calyculin A (100 nM) for 30 min, untreated
  Lane 2 : Human Jurkat cells treated with calyculin A (100 nM) for 30 min, treated with lambda phosphatase
  
  
  Predicted band size : 85 kDa
  Observed band size : 95 kDa (why is the actual band size different from the predicted?)
  Additional bands at : 105 kDa. We are unsure as to the identity of these extra bands.